46577 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 10
14:59 UTC
|
COO
Cooper Companies
|
◎ Target | Robbie Marcus ★★★★★ #318 | Neutral | $71.00→ $58.00-18.3% |
|
Sep 10
14:59 UTC
|
CON
Concentra Group Holdings Parent
|
◎ Target | Benjamin Rossi ★★★★★ #218 | Overweight | $34.00→ $43.00+26.5% |
|
Sep 10
14:59 UTC
|
BKR
Baker Hughes
|
◎ Target | Josh Silverstein ★★☆☆☆ #2447 | Neutral | $71.00→ $70.00-1.4% |
|
Sep 10
14:59 UTC
|
BIIB
Biogen
|
◎ Target | Morten Herholdt not yet tracked | Reduce | $165.00→ $175.00+6.1% |
|
Sep 10
14:59 UTC
|
AVAV
AeroVironment
|
◎ Target | Seth Seifman ★★★★☆ #802 | Overweight | $200.00→ $210.00+5.0% |
|
Sep 10
14:59 UTC
|
ABBV
AbbVie
|
◎ Target | Rajesh Kumar ★★★☆☆ #1515 | Buy | $300.00→ $315.00+5.0% |
|
Sep 10
14:59 UTC
|
AAL
American Airlines Group
|
◎ Target | Atul Maheswari ★★☆☆☆ #2771 | Buy | $18.00→ $17.00-5.6% |
|
Sep 10
14:59 UTC
|
BCRX
BioCryst Pharmaceuticals
|
↓ Downgrade | Brian Abrahams ★★☆☆☆ #2565 | Outperform→ Sector Perform | $13.00→ $11.00-15.4% |
|
Sep 10
14:59 UTC
|
AMGN
Amgen
|
↓ Downgrade | Morten Herholdt not yet tracked | Buy→ Hold | $445.00→ $425.00-4.5% |
|
Sep 10
14:59 UTC
|
PCAR
PACCAR
|
↑ Upgrade | Nick Housden not yet tracked | Sec→ r Perform ➝ Outperform | $130.00→ $150.00+15.4% |
|
Sep 10
14:59 UTC
|
NVS
Novartis
|
↑ Upgrade | Rajesh Kumar ★★★☆☆ #1515 | Reduce→ Hold | $123.00→ $136.00+10.6% |
|
Sep 10
13:59 UTC
|
SUNB
Sunbelt Rentals Holdings, Inc. Common Stock
|
◎ Target | Katie Fleischer not yet tracked | Overweight | $85.00→ $90.00+5.9% |
|
Sep 10
13:59 UTC
|
SIG
Signet Jewelers
|
◎ Target | Mauricio Serna ★★★☆☆ #1073 | Buy | $122.00→ $136.00+11.5% |
|
Sep 10
13:59 UTC
|
SAIL
SailPoint
|
◎ Target | Saket Kalia ★★★★☆ #919 | Overweight | $21.00→ $22.00+4.8% |
|
Sep 10
13:59 UTC
|
REGN
Regeneron Pharmaceuticals
|
◎ Target | Rajesh Kumar ★★★☆☆ #1515 | Buy | $800.00→ $920.00+15.0% |
|
Sep 10
13:59 UTC
|
PYXS
Pyxis Oncology
|
◎ Target | Robert Driscoll ★★★★☆ #924 | Outperform | $6.00→ $8.00+33.3% |
|
Sep 10
13:59 UTC
|
PSA
Public Storage
|
◎ Target | Brendan Lynch ★★★☆☆ #1730 | Equal Weight | $350.00→ $351.00+0.3% |
|
Sep 10
13:59 UTC
|
PFG
Principal Financial Group
|
◎ Target | John Nadel not yet tracked | Neutral | $98.00→ $120.00+22.4% |
|
Sep 10
13:59 UTC
|
ONC
BeOne Medicines
|
◎ Target | Peter Lawson ★★★★★ #294 | Overweight | $407.00→ $415.00+2.0% |
|
Sep 10
13:59 UTC
|
NAVN
Navan
|
◎ Target | Jared Levine ★★★☆☆ #2039 | Buy | $34.00→ $31.00-8.8% |
|
Sep 10
13:59 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Rajesh Kumar ★★★☆☆ #1515 | Buy | $150.00→ $172.00+14.7% |
|
Sep 10
13:59 UTC
|
LFST
LifeStance Health Group
|
◎ Target | Peter Warendorf ★★☆☆☆ #2398 | Overweight | $13.00→ $15.00+15.4% |
|
Sep 10
13:59 UTC
|
KFY
Korn/Ferry International
|
◎ Target | Joshua Chan ★★★☆☆ #1300 | Neutral | $75.00→ $82.00+9.3% |
|
Sep 10
13:59 UTC
|
JILL
J.Jill
|
◎ Target | Jonna Kim ★★★★☆ #875 | Hold | $18.00→ $22.00+22.2% |
|
Sep 10
13:59 UTC
|
JBLU
JetBlue Airways
|
◎ Target | Atul Maheswari ★★☆☆☆ #2771 | Sell | $5.00→ $4.00-20.0% |
|
Sep 10
13:59 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Etzer Darout ★★★☆☆ #2121 | Overweight | $270.00→ $271.00+0.4% |
|
Sep 10
13:59 UTC
|
IRD
Opus Genetics
|
◎ Target | Yun Zhong ★★☆☆☆ #2753 | Outperform | $10.00→ $13.00+30.0% |
|
Sep 10
13:59 UTC
|
GILD
Gilead Sciences
|
◎ Target | Morten Herholdt not yet tracked | Buy | $155.00→ $175.00+12.9% |
|
Sep 10
13:59 UTC
|
COO
Cooper Companies
|
◎ Target | Patrick Wood ★★★★☆ #543 | Neutral | $75.00→ $66.00-12.0% |
|
Sep 10
13:59 UTC
|
CNM
Core & Main
|
◎ Target | Matthew Bouley ★★★☆☆ #1511 | Overweight | $62.00→ $61.00-1.6% |
|
Sep 10
13:59 UTC
|
CHWY
Chewy
|
◎ Target | William Kerr not yet tracked | Buy | $34.00→ $32.00-5.9% |
|
Sep 10
13:59 UTC
|
CASY
Casey's General Stores
|
◎ Target | Bradley B. not yet tracked | Overweight | $970.00→ $780.00-19.6% |
|
Sep 10
13:59 UTC
|
CASY
Casey's General Stores
|
◎ Target | Mark Carden ★★★☆☆ #987 | Neutral | $925.00→ $720.00-22.2% |
|
Sep 10
13:59 UTC
|
BG
Bunge Global
|
◎ Target | Manav Gupta ★★★★☆ #580 | Buy | $145.00→ $155.00+6.9% |
|
Sep 10
13:59 UTC
|
AWK
American Water Works
|
◎ Target | Gregg Orrill ★★☆☆☆ #2854 | Buy | $156.00→ $162.00+3.8% |
|
Sep 10
13:59 UTC
|
AVAV
AeroVironment
|
◎ Target | Gavin Parsons ★★★☆☆ #2042 | Neutral | $166.00→ $170.00+2.4% |
|
Sep 10
13:59 UTC
|
ASO
Academy Sports and Outdoors
|
◎ Target | Michael Lasser ★★★★☆ #876 | Neutral | $55.00→ $58.00+5.5% |
|
Sep 10
13:59 UTC
|
ASO
Academy Sports and Outdoors
|
◎ Target | Adrienne Yih ★★★☆☆ #1643 | Equal Weight | $50.00→ $53.00+6.0% |
|
Sep 10
13:59 UTC
|
ALK
Alaska Air Group
|
◎ Target | Atul Maheswari ★★☆☆☆ #2771 | Buy | $56.00→ $52.00-7.1% |
|
Sep 10
13:59 UTC
|
AEO
American Eagle Outfitters
|
◎ Target | Jay Sole ★★★☆☆ #2211 | Buy | $31.00→ $27.00-12.9% |
|
Sep 10
13:59 UTC
|
AEO
American Eagle Outfitters
|
◎ Target | firm only | Market Perform | $20.00→ $18.00-10.0% |
|
Sep 10
13:59 UTC
|
BCRX
BioCryst Pharmaceuticals
|
↓ Downgrade | Brian Abrahams ★★☆☆☆ #2565 | Outperform→ Sector Perform | $11.00 |
|
Sep 10
13:59 UTC
|
KYMR
Kymera Therapeutics
|
↑ Upgrade | Andy Chen ★★★★☆ #618 | Peer Perform→ Outperform | $180.00 |
|
Sep 10
12:59 UTC
|
UPXI
Upexi
|
◎ Target | Gareth Gacetta not yet tracked | Overweight | $1.30→ $2.00+53.8% |
|
Sep 10
12:59 UTC
|
TYRA
Tyra Biosciences
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $45.00→ $30.00-33.3% |
|
Sep 10
12:59 UTC
|
SUNB
Sunbelt Rentals Holdings, Inc. Common Stock
|
◎ Target | Arnaud Lehmann not yet tracked | Underperform | $62.00→ $71.00+14.5% |
|
Sep 10
12:59 UTC
|
SUIG
Sui Group
|
◎ Target | Gareth Gacetta not yet tracked | Overweight | $1.70→ $3.40+100.0% |
|
Sep 10
12:59 UTC
|
SIG
Signet Jewelers
|
◎ Target | Lorraine Hutchinson ★★★☆☆ #1837 | Neutral | $102.00→ $115.00+12.7% |
|
Sep 10
12:59 UTC
|
SBET
Sharplink Gaming
|
◎ Target | Gareth Gacetta not yet tracked | Overweight | $8.30→ $17.00+104.8% |
|
Sep 10
12:59 UTC
|
PYXS
Pyxis Oncology
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2687 | Buy | $7.00→ $8.00+14.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.